The Anti-Ageing Expert: "I Have The Erection Of An 18 Year Old!", "This Food Reverses Your Age!", "This Oil Reduces Inflammation by 85%!"

Can we slow down ageing? Could we even reverse it? And, is death potentially optional? In this new episode Steven sits down again with entrepreneur, anti-aging and longevity pioneer Bryan Johnson. In 2007, Bryan founded the payment processing company ‘Braintree’, and was soon 47th on Inc. magazine’s list of the fastest growing companies in America. Bryan sold Braintree in 2013 for $800 million. Since then he founded ‘Project Blueprint’ in 2021. ‘Blueprint’ is an algorithmic approach to optimal health and ageing reversal, Bryan is their first test subject. In this conversation Bryan and Steven discuss topics, such as: Fighting against depression for a decade in his early 20’s Wondering whether life was worth living Struggling to balance religion, marriage, and depression. Trying to find ways to overcome depression How he was able to find freedom Breaking free from a toxic relationship The algorithm that controls human behaviour The impact of negative self-talk Understanding his self-destructive tendencies His daily battles against harmful actions Confronting death How humans are self-sabotaging Recognising society's illness and self-harm. Why there is a collective existential crisis Why driving is the most dangerous act The impact of sleep Why it is possible for humans to live forever How he will live to 125 years old Why olive oil reverses ageing How he is tricking his DNA to reverse ageing Why he is measuring his night time erections You can follow all the work and progress of Bryan and Blueprint here: https://bit.ly/3QP8VF2 Follow Bryan: Instagram: https://bit.ly/3rTLMaF Twitter: https://bit.ly/47hUDDi If you enjoyed this episode, I recommend you check out my first conversation with Bryan Johnson, which you can find here: https://www.youtube.com/watch?v=1yfoonW1InE Follow me: https://beacons.ai/diaryofaceo Learn more about your ad choices. Visit megaphone.fm/adchoices

There are no comments yet.

Please log in to write the first comment.